Latest Financial Results

Q1 2019

Quarterly Results

Ended Sep 30, 2018

Latest 10-K

Sign Up For E-Mail Alerts

Sign Up Today

Stock Information | View Detailed Stock Info

OTCQB: PPCB Propanc Biopharma, Inc.
Day Range
52 Week Range

Company Overview

Propanc is currently focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. We have developed a formulation of anti-cancer compounds which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Our products involve or employ proenzymes, which are inactive precursors of enzymes.

View Corporate Presentation

IR Contact Information

Transfer Agent

Corporate Stock Transfer Inc.
3200 Cherry Creek South Drive
Suite 430
Denver, CO 80209
T: 303-282-4800